CPSH on a New Growth Path: Q4 Revenue Jumps to $8.2M, Capex Plans Cast a Long Shadow Over 2026

Executive snapshot

• Stock and reporting basics: CPS Technologies Corporation, NASDAQ: CPSH; quarterly EPS: $0.00 per diluted share for the fourth quarter of fiscal 2025.
• Quarterly revenue: $8.2 million, up from $5.9 million in the prior-year period.
• Gross margin: 14.6% in Q4 2025, reversing a gross loss in the year-ago quarter.
• Operating and net results: operating loss of $0.1 million; net income essentially breakeven at $0.0 million (EPS $0.00).
• Capital actions: $9.5 million of net proceeds from a public offering (Oct 8, 2025) to fund general corporate purposes and expansion, including manufacturing capacity improvements.
• Strategic backdrop: CPS announced a $15.5 million follow-on order from a major semiconductor customer; management emphasizes expansion into a larger facility and continued revenue growth in 2026.
• Full-year context: 2025 revenue totaled $32.6 million, a 54% year-over-year increase, described as the strongest revenue result in the company’s history.
• Note on market expectations: The release does not provide an EPS consensus or a formal revenue forecast; as a result, an earnings surprise assessment against street expectations is not explicitly verifiable from the filing.

Fourth-quarter highlights

The CPSH press release frames the quarter as a sharp step up from 2024, anchored by stronger production rates and higher shipments. Notably, the gross margin improved to 14.6% from a negative margin a year earlier, underscoring a path toward operating leverage as the company scales.

Results of operations

CPS reported fourth-quarter revenue of $8.2 million, up from $5.9 million in the prior-year period, signaling stronger demand for its core product lines and favorable production dynamics. Gross profit came in at $1.2 million (14.6% of revenue), reversing a gross loss of about $0.3 million in the fiscal 2024 fourth quarter.

Operating loss narrowed to $0.1 million for the quarter, compared with a $1.3 million loss in the prior-year period. Selling, general and administrative expenses totaled $1.3 million during the quarter, reflecting higher variable compensation aligned with revenue growth and increased sales commissions tied to stronger top-line performance. Net income for the quarter was essentially $0.0 million, or $0.00 per diluted share, versus a net loss of about $1.0 million, or $(0.07) per diluted share, in the quarter ended December 28, 2024.

Management highlighted a key order win during the quarter—a $15.5 million follow-on order with a major multinational semiconductor manufacturer—an indicator of CPS’s ongoing relevance in a competitive supply chain. The release also notes that higher gold prices contributed to revenue dynamics, which may have implications for cost structures and product mix in the near term.

Capital actions and strategic trajectory

In October 2025, CPS closed a public offering that netted about $9.5 million to be used for general corporate purposes, including expanding CPS’s production capabilities through the move to a larger facility. The combination of a sizable follow-on order and this capital raise points to a deliberate push to lift production capacity while preserving financial flexibility.

CEO statements in the release underscore a narrative of momentum and opportunity: 2025 closed as the company’s best revenue year to date, with a plan to accelerate production, broaden the product portfolio, and explore new markets. The leadership also hints at evaluating sites for a larger, advanced CPS manufacturing facility and aims to complete the transition over the course of 2026. These are big bets that hinge on execution, supplier stability, and the ability to translate capacity into margin expansion.

Implications for CPSH and industry peers

The 2025 results place CPSH on a runway where revenue growth meets the practical constraints of manufacturing scale. The quarterly improvement in gross margin suggests early-stage operating leverage, but the ongoing split between revenue growth and profitability will be the defining story as the company ramps capacity. The public offering, coupled with a meaningful order book, reduces near-term liquidity risk and provides a plausible path to financing future capex without crippling the balance sheet.

For peers in the semiconductor equipment and specialty materials space, CPSH’s trajectory reinforces a few macro themes: end-market demand volatility can be offset by strategic capital raises; evidence of customer concentration appears to be softened by a high-value, top-line order; and long-cycle investments in manufacturing capacity become the lever for converting revenue gains into durable margins. A potential pitfall to monitor is how rising production costs and raw-material dynamics (including the noted sensitivity to gold price movements) intersect with pricing discipline and demand cyclicality.

From an investment lens, the absence of a stated EPS consensus or revenue forecast in the filing means the market will lean on management commentary and subsequent quarterly updates to gauge whether 2026 revenue growth can sustain the positive momentum. An earnings surprise in the traditional sense isn’t clearly flagged here, but a credible path to sustained margin expansion alongside revenue growth could reframe CPSH’s pricing power and capital-return profile in the eyes of long-term investors.

Bottom line

CPS Technologies Corporation has delivered a convincing quarterly rebound, with $8.2 million in quarterly revenue, a return to gross profitability, and a demonstrable appetite for expansion. The 2025 full-year performance—$32.6 million in revenue, up 54%—establishes a credible platform for growth, anchored by a notable $15.5 million follow-on order and a capital raise aimed at capacity expansion.

What comes next will hinge on execution: converting capacity into margin leverage, translating the new facility ambitions into faster throughput, and crystallizing a forward-looking revenue path that can anchor an EPS trajectory. For CPSH and its sector peers, the narrative remains simple and stubborn: invest in capability, manage the variable costs of growth, and hope demand doesn’t hit the brakes. As always in the capital-intensive world of growth-stage manufacturing, the real test is how quickly a company can turn every incremental dollar of revenue into a sustainable profit line.